Back

The association between SGLT2 inhibitors and Incident Dementia in patients with heart failure: A Population-Based Longitudinal Cohort Study

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Comorbidities in heart failure Diabetes and the Heart HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Gwo-Ping Jong

Chung Shan Medical University Hospital, Taichung (Taiwan)

5 More presentations in this session

Presentation thumbnail
Impact of diabetes and glycemic status on ventricular-arterial coupling (VAC) in the general population
Mr H. Zilic (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
Non-dilated left ventricular cardiomyopathy in patients with chronic Chagas disease
Professor R. Bestetti (Ribeirao Preto, BR)
Abstract Slides Video
Presentation thumbnail
Left atrial strain: is it a must do
Professor S. Tadic (Novi Sad, RS)
Abstract Slides Video
Presentation thumbnail
Management of cardio-kidney-metabolic syndrome: a spanish multidisciplinary Delphi consensus.
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides Video
Presentation thumbnail
Real-world eligibility for finerenone in diabetic patients with chronic kidney disease: insights from the FIDELITY pooled analysis
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities in heart failure

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
SGLT2 inhibitor for secondary prevention in acute myocardial infarction patients with diabetes mellitus
thumbnail
Congress Presentation
Real-world use of empaglifozin and dapaglifozin in patients with HEART failure
thumbnail
Congress Presentation
Unlocking SGLT2 inhibitors: evaluating elderly HFrEF patients with and without T2DM

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources